28
Oct
2025

Rafarm S.A

Exhibitor at CPHI Frankfurt 2025 stand 9.2D24, Integrated Pharma
About Us

Rafarm is a Greek pharmaceutical company with extended experience in the development, manufacturing, out-licensing and marketing of pharmaceutical products. We grow together; Planning with care for the future by continuously investing in our GMP facility and strong team of qualified professionals, in order to deliver to you, a wide range of products and services fully customized to suit your needs. Specialized in ophthalmic and sterile products, we also offer solids, semisolids, liquids and creams always implementing our philosophy “Health care. Human care.”. Today we celebrate ov...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • GR
  • 2015
    On CPHI since
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 9.2D24, Integrated Pharma

Products Featured at CPHI Frankfurt 2025

  • MOXIFLOXACIN HYDROCHLORIDE eye drops solution

    Product MOXIFLOXACIN HYDROCHLORIDE eye drops solution

    Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial Conjunctivitis Innovator: Moxivig (Novartis)
  • CLOPIDOGREL BESILATE f.c. tablets

    Product CLOPIDOGREL BESILATE f.c. tablets

    Strength: 75 mg/tab Therapeutic area: Anti-thrombotic Innovator: Plavix (Sanofi-Aventis)
  • AMIKACIN solution for injection

    Product AMIKACIN solution for injection

    Strength: 500 mg/2 ml Presentation: vials, 2 ml Therapeutic area: Anti-infective Innovator: Briklin 
  • ATORVASTATIN f.c. tablets

    Product ATORVASTATIN f.c. tablets

    Strength: 10 mg/tab; 20 mg/tab; 40 mg/tab; 80 mg/tab Therapeutic area: Hypercholesterolaemia & Prevention of Cardiovascular Diseases Innovator: Lipitor (Pfizer)
  • BIMATOPROST + TIMOLOL eye drops solution

    Product BIMATOPROST + TIMOLOL eye drops solution

    Strength: (0.3 mg+5 mg)/ml Presentation: vials, 3 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Ganfort (Allergan)
  • BIMATOPROST eye drops solution

    Product BIMATOPROST eye drops solution

    Strength: 0.3 mg/ml; 0.1 mg/ml Presentation: vials, 3 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Lumigan (Allergan)
  • BRIMONIDINE + TIMOLOL eye drops solution

    Product BRIMONIDINE + TIMOLOL eye drops solution

    Strength: (2 mg+5 mg)/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Combigan (Allergan)
  • BRIMONIDINE eye drops solution

    Product BRIMONIDINE eye drops solution

    Strength: 2 mg/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Alphagan (Allergan)
  • DEXAMETHASONE PRESERVATIVE FREE eye drops solution

    Product DEXAMETHASONE PRESERVATIVE FREE eye drops solution

    Strength: 1 mg/ml Presentation: vials, 5 ml Therapeutic area: Treatment of inflammatory conditions of the anterior segment of the eye Innovator: Dexafree (Laboratoires THEA)
  • DEXAMETHASONE soluble tablets

    Product DEXAMETHASONE soluble tablets

    Strength:  0.5 mg/tab; 2 mg/tab; 4 mg/tab; 8 mg/tab; 10 mg/tab; 20 mg/tab Therapeutic area: Glucocorticoid Therapy Innovator: - (-)
  • DONEPEZIL f.c. tablets

    Product DONEPEZIL f.c. tablets

    Strength: 5 mg/tab; 10 mg/tab Therapeutic area: Alzheimer's Dementia Innovator: Aricept (Pfizer)
  • DONEPEZIL oral solution

    Product DONEPEZIL oral solution

    Strength: 1 mg/ml Presentation: bottles, 150 ml Therapeutic area: Alzheimer's Dementia Innovator: Aricept (Pfizer)
  • DORZOLAMIDE + TIMOLOL eye drops solution

    Product DORZOLAMIDE + TIMOLOL eye drops solution

    Strength: (20 mg+5 mg)/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Cosopt (Merk & Co)
  • DORZOLAMIDE eye drops solution

    Product DORZOLAMIDE eye drops solution

    Strength: 20 mg/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Trusopt (Merk & Co)
  • DUTASTERIDE soft gel capsules

    Product DUTASTERIDE soft gel capsules

    Strength: 0.5 mg/cap Therapeutic area: Benign Prostatic Hyperplasia Innovator: Avodart (GSK)
  • ELETRIPTAN f.c. tablets

    Product ELETRIPTAN f.c. tablets

    Strength: 20 mg/tab; 40 mg/tab; 80 mg/tab Therapeutic area: Migraine Treatment Innovator: Relpax (Pfizer)
  • EZETIMIBE tablets

    Product EZETIMIBE tablets

    Strength: 10 mg/tab Therapeutic area: Primary Hypercholesterolaemia, Homozygous Familial Hypercholesterolaemia, Homozygous Sitosterolaemia Innovator: Ezetrol (Merck & Co)
  • FERROUS GLUCONATE effervescent granules

    Product FERROUS GLUCONATE effervescent granules

    Strength: 695 mg (80 mg/Fe++)/sachet Presentation: single dose sachet Therapeutic area: Iron Deficiency Innovator: Viofer (Viofar)
  • ILOPROST concentrate solution for infusion

    Product ILOPROST concentrate solution for infusion

    Strength: 20 mcg/ml; 100 mcg/ml Presentation: ampoules, 0.5 ml (100 mcg/ml); 1 ml (20 mcg/ml & 100 mcg/ml); 2.5 ml (20 mcg/ml) Therapeutic area: Severe peripheral arterial occlusive disease (PAOD) Innovator: Ilomedin (Bayer)
  • ILOPROST nebulizer solution

    Product ILOPROST nebulizer solution

    Strength: 10 mcg/ml; 20 mcg/ml Presentation: ampoules, 1 ml & 2 ml Therapeutic area: Pulmonary hypertension Innovator: Ventavis (Bayer)
  • IRON SUCROSE COMPLEX solution for injection/concentrate solution for infusion

    Product IRON SUCROSE COMPLEX solution for injection/concentrate solution for infusion

    Strength: 20 mg Iron/ml Presentation: ampoules, 5 ml & vials, 5 ml Therapeutic area: Iron Deficiency Innovator: Venofer (Vifor)
  • LATANOPROST + TIMOLOL eye drops solution

    Product LATANOPROST + TIMOLOL eye drops solution

    Strength: (50 mcg+5 mg)/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalacom (Pfizer)
  • LATANOPROST eye drops solution

    Product LATANOPROST eye drops solution

    Strength: 50 mcg/ml Presentation: vial, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalatan (Pfizer)
  • LATANOPROST PRESERVATIVE FREE eye drops solution

    Product LATANOPROST PRESERVATIVE FREE eye drops solution

    Strength: 50 mcg/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalatan (Pfizer)
  • LEVOCARNITINE solution for injection

    Product LEVOCARNITINE solution for injection

    Strength: 1 g/5 ml; 2 g/5 ml Presentation: ampoules, 5 ml Therapeutic area: Carnitine Deficiency Innovator: Carnitor (Sigma-Tau)
  • LEVOFLOXACIN eye drops solution

    Product LEVOFLOXACIN eye drops solution

    Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial external ocular infections Innovator: Oftaquix (Santen)
  • LEVOFLOXACIN PRESERVATIVE FREE eye drops solution

    Product LEVOFLOXACIN PRESERVATIVE FREE eye drops solution

    Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial external ocular infections Innovator: Oftaquix (Santen)
  • OLOPATADINE eye drops solution

    Product OLOPATADINE eye drops solution

    Strength: 1 mg/ml Presentation: vials, 5 ml Therapeutic area: Allergic Conjunctivitis Innovator: Opatanol (Alcon)
  • PALONOSETRON solution for injection

    Product PALONOSETRON solution for injection

    Strength: 250 mcg/5ml Presentation: vials, 5 ml Therapeutic area: Acute Nausea & Vomiting Innovator: Aloxi (Helsinn Birex)
  • PARICALCITOL soft gel capsules

    Product PARICALCITOL soft gel capsules

    Strength: 1 mcg/cap; 2 mcg/cap; 4 mcg/cap Therapeutic area: Secondary Hyperparathyroidism Innovator: Zemplar (Abbott)
  • PARICALCITOL solution for injection

    Product PARICALCITOL solution for injection

    Strength: 2 mcg/ml; 5 mcg/ml Presentation: ampoules, 1 ml (2 mcg/ml & 5 mcg/ml) & 2 ml (5 mcg/ml); vials, 1 ml (2 mcg/ml & 5 mcg/ml) & 2 ml (5 mcg/ml) Therapeutic area: Secondary Hyperparathyroidism Innovator: Zemplar (Abbott)
  • PRAMIPEXOLE tablets

    Product PRAMIPEXOLE tablets

    Strength: 0.088 mg/tab; 0.18 mg/tab; 0.35 mg/tab; 0.7 mg/tab Therapeutic area: Idiopathic Parkinson's Disease & Idiopathic restless legs syndrome Innovator: Mirapexin (Boehringer Ingelheim)
  • SODIUM CROMOGLICATE PRESERVATIVE FREE eye drops solution

    Product SODIUM CROMOGLICATE PRESERVATIVE FREE eye drops solution

    Strength: 20 mg/ml Presentation: vials, 5 ml & 10 ml Therapeutic area: Relief and treatment of seasonal and perennial allergic conjunctivitis Innovator: Opticrom (Sanofi)
  • TOBRAMYCIN + DEXAMETHASONE eye drops suspension

    Product TOBRAMYCIN + DEXAMETHASONE eye drops suspension

    Strength: (3 mg+1 mg)/ml Presentation: vials, 5 ml Therapeutic area: Intraocular inflammation & ocular surface bacterial contamination Innovator: Tobradex (Alcon-Novartis)
  • TRAVOPROST + TIMOLOL eye drops solution

    Product TRAVOPROST + TIMOLOL eye drops solution

    Strength: (40 mcg+5 mg)/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: DuoTrav (Alcon-Novartis)
  • TRAVOPROST eye drops solution

    Product TRAVOPROST eye drops solution

    Strength: 40 mcg/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Travatan (Alcon-Novartis)
  • ZOLEDRONIC ACID concentrate solution for infusion

    Product ZOLEDRONIC ACID concentrate solution for infusion

    Strength: 4 mg/5 ml Presentation: vials, 5 ml Therapeutic area: Skeletal Related Events in Advanced Malignancies & Tumour-Induced Hypercalcaemia Innovator: Zometa (Novartis)
  • ROSUVASTATIN CALCIUM f.c. tablets

    Product ROSUVASTATIN CALCIUM f.c. tablets

    Strength: 5 mg/tab; 10 mg/tab; 20 mg/tab Therapeutic area: Hypercholesterolaemia & Prevention of Cardiovascular Events Innovator: Crestor (AstraZeneca)
  • TOBRAMYCIN eye drops solution

    Product TOBRAMYCIN eye drops solution

     Strength: 3 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial Infections Innovator: Tobrex (Alcon)